Program: 7:30 AM - 9:00 AM Registration Begins 30 minutes prior.
Whether you are a director of a public or a private company, there are times of crisis that will accelerate the need to replace your CEO, “divorce” a director or even respond to viral social media “attacks” or product/operational meltdowns that affect your customers and stakeholders. These crises can quickly and significantly affect not only your company’s financials but they can also deeply can impact your company’s reputation. If lucky your company and its Board can manage the transition with as little pain and fanfare as possible. At other times you will find yourself dealing with troubled investors or customers, impacted communities, inquisitive regulators and the dreaded press leak.
Hear from some of New England’s most experienced and notable independent directors as they share their stories and insights on strategies for handling these important and thorny issues.
Directors and those who are responsible for board level activities will learn:
What kinds of situations lead up to these events
How to identify potential crisis hot spots in advance
When and how to respond to different types of crises
How to construct a crisis management plan and crisis management team
How to avoid the potential crisis altogether – if at all possible.
About our Panel:
Terry Carelton, CFA is a financial advisor with UBS Private Wealth Management in Boston and a Board Member of Demoulas Super Markets, Inc. Company. He has served as chair of Bentley University’s Board of Trustees and later filled the role of the University's president (although without the title or the salary) from 2005-2007. He led the transition of Bentley's reclassification from a college to a university while also overseeing a period of major expansion in academic, residential and athletic/recreational facilities during his time as trustees' chair from 2005-2012. Carleton has served on the board of Caritas Hospital in Norwood, Mass. for 11 years and is currently chair of the Newton Country Day School board. He began his career at Kidder, Peabody & Co., where he was consistently recognized by Institutional Investor as an “All-Star Analyst.” He went on to help build and successfully monetize two nationally recognized private companies before joining UBS in 2009.
Alison Taunton-Rigby, Ph.D., O.B.E., has been President and Chief Executive Officer of several public and private companies in the life science and healthcare industries. She currently serves as a Director on a number of public, private, non-profit, ESOP and mutual fund boards, including Columbia Funds, Healthways, Inc., Abt Associates, Inc., ICI Mutual Insurance Company, and Boston Children's Hospital. Dr. Taunton-Rigby was Founder, President and Chief Executive Officer of RiboNovix, Inc.; President and Chief Executive Officer of Aquila Biopharmaceuticals, Inc.; Cambridge Biotech Corporation; and Mitotix Inc. Prior to this she was a Senior Executive at Genzyme Corporation,; Arthur D. Little,,Inc.; Vivotech Inc.,;Biogen, Inc.; and Collaborative Research, Inc. In 2002 Dr. Taunton-Rigby was awarded the OBE (Officer of the Order of the British Empire) by Queen Elizabeth II for her work as a leader in the research, development and promotion of biotechnology. In 2009 she was awarded an honorary D.Sc. by the University of Bristol, UK.
Ed Pendergast is the Managing Director of the investment banking firm Dunn Rush & Co LLC. His directorship experience includes public, private and non-profit organizations in a variety of industries from technology to retail. His governance role has included Chair of the Board, Lead Director of the Board and Interim CEO in two companies, Financial Expert on Auditing Committees, and he has served on Nominating, Compensation and Governance Committees. Ed is on the faculty of the Board Advisory Services section of the National Association of Corporate Directors (NACD), providing in board room education, evaluations and consulting. He is an NACD Board Leadership Fellow. Ed is a CPA, having merged his practice with a national CPA firm where he served as National Director of Planning.
Kathy Cuocolo, CPA, former EVP State Street Corporation, is an accomplished business leader and board director who developed several new businesses within Asset Management and led them to great P&L success. She has been described as a serial intrapreneur for building these businesses within State Street Corporation, each of which capitalized on clients’ needs to adapt to regulatory change and manage the risk surrounding same. She has over thirteen years of board experience, having served as Chair of the Board of Select Sectors Trust, Audit Chair of the Citigroup Alternative Investment Trust, Independent Director of the Guardian Life Family of Funds, and President and Director of The China Fund. Kathy has traveled widely, managing investment services in Europe and China. Currently Kathy is an independent director of Greenback Renewable Energy LLC, a solar and wind operator in the US. She holds a Masters Professional Director Certification from the American College of Corporate Directors, a public company director education and credentialing organization.